Amundi’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Amundi's PCRX Position: Q3 2026 in Review
Amundi increased its Pacira BioSciences (PCRX) stake by 27% in Q3 2026, buying an estimated $110K and bringing the position to 20,224 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.
Amundi first reported a position in PCRX in Q2 2021 and has held it in 13 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Amundi held 20,224 shares of Pacira BioSciences worth $507K as of Q3 2026.
- Amundi bought 4,330 Pacira BioSciences shares in Q3 2026, an estimated $110K.
- Pacira BioSciences made up ﹤0.01% of Amundi's portfolio in Q3 2026, its #1654 holding.
- Amundi first reported a position in Pacira BioSciences in Q2 2021 and has held it in 13 quarters since.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.